|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV033120234 |
| 003 |
DE-627 |
| 005 |
20230623224646.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2013 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/S0378-3782(13)70002-1
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2013012000013.pica
|
| 035 |
|
|
|a (DE-627)ELV033120234
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(13)70002-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Bancalari, Eduardo
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Strategies to accelerate weaning from respiratory support
|
| 264 |
|
1 |
|c 2013
|
| 300 |
|
|
|a 3
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Because mechanical ventilation is associated with severe complications in premature infants, it is important to limit its duration as much as possible. This can be accomplished by using startegies that preserve spontaneous respiration such as patient triggered and volume target ventilation. The use of respiratory stimulants and nasal CPAP or nasal IPPV after extubation are also effective and improve extubation success. A short course of systemic steroids can also expedite weaning and extubation.
|
| 650 |
|
7 |
|a Premature
|2 Elsevier
|
| 650 |
|
7 |
|a Respiratory failure
|2 Elsevier
|
| 650 |
|
7 |
|a Extubation
|2 Elsevier
|
| 700 |
1 |
|
|a Claure, Nelson
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:89
|g year:2013
|g pages:4-6
|g extent:3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(13)70002-1
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 89
|j 2013
|h 4-6
|g 3
|y 89.2013, S4-, (3 S.)
|
| 953 |
|
|
|2 045F
|a 610
|